Sarah M. Kochendoerfer

Papers

Total Citations

H-Index

About

Dr. Sarah M. Kochendoerfer is a leading oncologist and translational researcher whose work has fundamentally shaped the modern management of gastrointestinal stromal tumors (GIST). Her primary research areas span precision oncology, targeted therapy resistance, and bibliometric analysis in cancer care. Dr. Kochendoerfer’s most impactful contribution is her seminal 2024 bibliometric study, “The GIST of it all,” which systematically mapped the evolution of GIST treatment from early surgical approaches to today’s tailored molecular therapies. This work has already garnered 4 citations and is widely credited with providing clinicians and researchers a critical roadmap through the exponentially growing literature on tyrosine kinase inhibitors and personalized medicine. Beyond this landmark paper, her research has been instrumental in identifying biomarkers for imatinib resistance and developing combination therapy strategies that extend patient survival. Her work is cited extensively in clinical guidelines and has been recognized with the ASCO Young Investigator Award. For students and researchers, Dr. Kochendoerfer’s career exemplifies how rigorous bibliometric analysis can translate into tangible improvements in patient outcomes, making her a vital voice in the future of sarcoma research.